All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
This invention relates generally to medical devices used during vascular intervention, and more particularly, concerns medical devices that are useful in treating aortic valve replacement, thromboembolic disorders and for removal of foreign bodies in the vascular system.
Thromboembolic disorders, such as stroke, pulmonary embolism, peripheral thrombosis, atherosclerosis, and the like, affect many people. These disorders are a major cause of morbidity and mortality in the United States and throughout the world. Thromboembolic events are characterized by an occlusion of a blood vessel. The occlusion can be caused by a clot which is viscoelastic (jelly-like) and is comprised of platelets, fibrinogen, and other clotting proteins.
Percutaneous aortic valve replacement has been in development for some time now and stroke rates related to this procedure are between four and twenty percent. During catheter delivery and implantation plaque may be dislodged from the vasculature. The invention contained within will block the emboli from traveling through the carotid circulation and onto the brain. When an artery is occluded by a clot, tissue ischemia (lack of oxygen and nutrients) develops. The ischemia will progress to tissue infarction (cell death) if the occlusion persists. Infarction does not develop or is greatly limited if the flow of blood is reestablished rapidly. Failure to reestablish blood-flow can lead to the loss of limb, angina pectoris, myocardial infarction, stroke, or even death.
Occlusion of the venous circulation by thrombi leads to blood stasis which can cause numerous problems. The majority of pulmonary embolisms are caused by emboli that originate in the peripheral venous system. Reestablishing blood flow and removal of the thrombus is highly desirable.
There are many existing techniques employed to reestablish blood flow in an occluded vessel. One common surgical technique, an embolectomy, involves incising a blood vessel and introducing a balloon-tipped device (such as a Fogarty catheter) to the location of the occlusion. The balloon is then inflated at a point beyond the clot and used to translate the obstructing material back to the point of incision. The obstructing material is then removed by the surgeon. While such surgical techniques have been useful, exposing a patient to surgery may be traumatic and is best avoided when possible. Additionally, the use of a Fogarty catheter may be problematic due to the possible risk of damaging the interior lining of the vessel as the catheter is being withdrawn.
A common percutaneous technique is referred to as balloon angioplasty where a balloon-tipped catheter is introduced into a blood vessel, typically through an introducing catheter. The balloon-tipped catheter is then advanced to the point of the occlusion and inflated in order to dilate the stenosis. Balloon angioplasty is appropriate for treating vessel stenosis but is generally not effective for treating acute thromboembolisms.
Another percutaneous technique is to place a microcatheter near the clot and infuse Streptokinase, Urokinase, or other thrombolytic agents to dissolve the clot. Unfortunately, thrombolysis typically takes hours to days to be successful. Additionally, thrombolytic agents can cause hemorrhage and in many patients the agents cannot be used at all.
Another problematic area is the removal of foreign bodies. Foreign bodies introduced into the circulation can be fragments of catheters, pace-maker electrodes, guide wires, and erroneously placed embolic material such as thrombogenic coils. There exist retrieval devices for the removal of foreign bodies, certain of such devices form a loop that can ensnare the foreign material by decreasing the size of the diameter of the loop around the foreign body. The use of such removal devices can be difficult and sometimes unsuccessful.
Moreover, systems heretofore disclosed in the art are generally limited by size compatibility and the increase in vessel size as the emboli is drawn out from the distal vascular occlusion location to a more proximal location near the heart. If the embolectomy device is too large for the vessel it will not deploy correctly to capture the clot or foreign body, and if too small in diameter it cannot capture clots or foreign bodies across the entire cross section of the blood vessel. Additionally, if the embolectomy device is too small in retaining volume then as the device is retracted the excess material being removed can spill out and be carried by flow back to occlude another distal vessel.
Various thrombectomy and foreign matter removal devices have been disclosed in the art. However, such devices have been found to have structures which are either highly complex or lacking in sufficient retaining structure. Disadvantages associated with the devices having highly complex structure include difficulty in manufacturability as well as difficulty in use in conjunction with microcatheters. Recent developments in the removal device art features umbrella filter devices having self folding capabilities. Typically, these filters fold into a pleated condition, wherein the pleats extend radially and can obstruct retraction of the device into the micro catheter sheathing.
What has been needed and heretofore unavailable is an extraction device that can be easily and controllably deployed into and retracted from the circulatory system for the effective removal of clots and foreign bodies. There is also a need for a system that can be used as a temporary arterial or venous filter to capture and remove thromboemboli generated during endovascular procedures. Moreover, due to difficult-to-access anatomy such as the cerebral vasculature and the neurovasculature, the invention should possess a small collapsed profile and preferably be expandable to allow the device to be delivered through the lumen of commercially available catheters. The present invention satisfies these needs.
Most filter devices are delivered from the groin and are placed distal to the flow of the lesion or site in question. Single basket-type filters or Nitinol loop filters are the most common used today in carotid stent procedures of vein graft stenting. As the guidewire is delivered past the lesion the filter is delivered over the guidewire protecting the distal vasculature. The invention here may be delivered from the groin in a conventional manner to vessels such as the carotid arteries or via radial (arm vasculature) approach. Protecting the carotid arteries and cerebral vasculature system is the main goal while leaving the aortic arch free from catheters and wire as much as possible during the delivery of other devices such as aortic balloons and prosthetic valves or other associated devices.
One method of filtering the carotid arteries leaving the aorta free from obstruction is to deliver a filter to each of the carotid arteries from the groin leaving them in the carotid vasculature and retrieving them via snare post procedure. A delivery catheter would be inserted through an introducer in the groin (femoral artery) and delivered to the common carotid arteries and detached. The delivery catheter would be removed and a second filter would be delivered in a similar manner to the other carotid artery. With two detached filters now in place the procedure treating the aortic or mitral valve can now be completed with embolic protection for the cerebral vascular system. Once the procedure to the valve is completed, the filters can be snared and retrieved back out the femoral artery as they were delivered. Any embolic particles will be captured in the filter device and removed safely from the body.
Another method for filtering the carotid arteries would be to deliver a filter from the femoral artery and utilize a single catheter to house the two attachment means to the filters. These attachments may be a wire similar to a guidewire or a hypo-tube to connect the filter element to an external portion of the body. Keeping these wires or connection means organized and contained within a single or dual lumen catheter will help organize and limit potential entanglement with other catheters being delivered to the target site such as the aortic valve or other cardiac elements including but not limited to the mitral valve and coronary arteries. The distal portion of the catheter may have a single exit portion or a staggered exit to allow an exit at different points along the catheter. One exit port may be at the distal most end of the catheter and the other may be a centimeter proximal from this to allow the attachment wire to exit near the left common carotid artery. Furthermore, there could be an extension to the distal most portion of the catheter allowing side ports for both wires to exit. This would allow for additional catheter stabilization within the aorta.
Another embodiment would deliver filters to the carotid from the radial artery and allow for a clear aortic arch from catheters and other delivery means from a more conventional femoral delivery means. From this access site a plurality of filters could be delivered through a common access sheath or the filters could be delivered from a dual lumen catheter with each lumen housing a single filter.
Another delivery means would utilize a single catheter with filters mounted in a coaxial manner where the distal filter would be delivered first and could be mounted to a wire where the second would be mounted to a hypo-tube where the first filters wire would run through the second allowing for relative motion between the two filters. The first filter would be delivered to the left common carotid from the radial artery and the second would be delivered to the right common carotid artery or the brachiocephalic trunk in a coaxial manner. These filters would be opposed in direction as the distal filter would be filtering blood flowing from the base of the aorta to the head and toward the distal end of the guidewire. The proximal filter would be filtering blood from the base of the aorta to the head and toward the proximal end of the guidewire. Placing the two filters together there would be a conical shape configuration where the large diameter portions of the cones would meet. These two filters would be delivered in a collapsed configuration and expanded when expelled from the delivery catheter. Retrieval would be a retraction of the filter back into a recovery catheter that would be a larger inner diameter than the delivery catheter to allow room for particulate. Being opposed in capture direction the right carotid would be the first filter that would be recovered by an expanded sheath where the embolic material would not be disturbed and further withdrawn to a smaller sheath for removal from the body. The expanded sheath could be constructed from braided Nitinol wire pre-shaped so when exposed the braid would expand to receive the filter without squeezing out any trapped emboli. The second or left carotid filter would be recovered in a conventional manner where the larger diameter would be pulled into a sheath to trap and remove the emboli within the tailor distal portion of the filter.
Another means to deliver the filters via radial artery approach would be to utilize a dual lumen catheter where each lumen would house a single filter. The first lumen would deliver a filter to the left carotid artery and the second lumen would deliver a filter to the right carotid artery. The lumens could be staggered in length to reach each ostium in which case the first or left filter lumen would be longer in length to allow for placement distal from the second filter placement in the right carotid. Additionally, the second lumen may be pre-shaped with a curve to allow easy access to the right carotid artery. This pre-shaped curve may be retained in a straighter manner to allow for delivery and released to express the delivery shape when at the bifurcation of the subclavian and the carotid artery. Furthermore, there may be an active shaping where the curve is directed external to the body by a handle mechanism such as a pull-wire where tension would generate a compressive force to the catheter column preferentially bending the lumen. Recovery could utilize the same dual lumen concept or utilize a second recovery sheath independently from one another.
Another application for this device and method would be for surgical operations where the patient may be put on heart-lung bypass. During cross clamping of the aorta catheters or wires in the aorta may interfere with the procedure and allow leakage of blood around the cannulas used. If any of the above described devices or techniques are used before the patient's chest is opened this filtration of the carotid vessels would protect from emboli thus reducing the stroke risk during and after the procedure. Additional anti thrombotic coatings to the filter could allow for an extended implantation time allowing filtration time to be extended post procedure. An example of this coating would be Heparin. Placement of these catheters and filters could be under fluoroscopy or ultrasound guidance to direct proper filter placement. Radiopaque markers may add necessary visibility to the catheter, filter and or wires.
Another surgical delivery means would be an insertion to the carotid artery via the neck. The filter could face either antigrade or retrograde depending upon the placement insertion point or access site. This would allow for complete filtration without any aortic interference as the entire devices would be within the carotid circulation. With this delivery technique the puncture site would be very small and recovery could be through the entry site or through the groin as the filter could be inserted distal to meet a recovery sheath in the aorta. With this groin recovery any emboli within the proximal carotid would be captured before later dislodgement.
Intravascular filters have been used in many configurations ranging from a windsock style as commercialized as the FilterWire from Boston Scientific or the ACCUNET from Abbott Vascular or the Spider from eV3. These filters utilize a memory metal such as Nitinol is used to oppose the vascular wall tightly sealing any emboli from passage while a filter material such as a porous fabric material retains and emboli from passing distally from the device. Another example is a laser cut memory metal where the basket is the frame and the filter is used to trap emboli when expanded. Another example is constructed from a braided wire such as Medtronic's Interceptor PLUS where once exposed the braid expands to create a funnel or cone shape to trap emboli and the proximal or larger end is pre-shaped to accept blood flow with larger openings heat-set into the memory metal such as Nitinol. These filters range in diameter from about 2-15 mm in diameter and are approximately 20-30 mm in length. They are generally attached to a guidewire and sheathed for delivery and resheathed for recovery. The catheter profile measures about 1 to 2 mm in diameter and has a length of about 90 to 200 cm. Catheter construction is normally a polypropylene or polyethylene material but nylons and blends can be used as well. All devices are considered single use and are commonly placed for carotid stenting or savenous vein grafts stenting.
Before standard intervention would occur by a cardiologist a filter would be placed into the carotid arteries to protect the circulation to the brain where emboli could induce a stroke and leave the patient debilitated. Placement of these filters to the patient's carotid circulation would be most convenient if it occurred without obstruction of the aorta where other catheters would be passed and preferably on the patient's right side as it is common practice for the doctor to steer the catheters from this side of the table. Standard practice is to gain access in the right femoral artery where a sheath would be placed to introduce catheters, guidewires and other device delivery means. This would leave the left femoral artery open but often it too is used for other diagnostic catheters and it is less convenient to work across the patient's body. Other access sites would include carotid entry but the neck area is often again inconvenient to operate from and generally too far from the other wires and catheters. The final entry point would be an arm entry where a sheath would be placed into the brachial or radial artery for access to the subclavian artery and more distally the aorta and the carotid arteries. This approach would allow the doctor to access the patient's right arm placing a sheath into the radial artery and delivering catheters, guidewires and sheaths to the carotid arteries. After a 5 French sheath placement a guide catheter would be placed into the radial artery and advanced to the brachiocephalic trunk where the right carotid artery meets the subclavian. From here a curve in the guide catheter would allow a 180 turn to occur accessing from the brachiocephalic trunk into the aortic arch and back up the left carotid artery which is commonly found one centimeter down the aortic arch. Once the guide catheter is place a filter may be advanced into the left carotid artery and deployed leaving this vessel protected from emboli. The guide catheter could be moved proximally to leave this vasculature and back into the brachiocephalic trunk artery where a coaxial filter could now be placed protecting this carotid artery. The connection between the two filters is a common axial link where the distal or left carotid filter would be attached to a 0.014 inch guidewire as normally constructed and the more proximal filter would utilize a tubular member such as a polymer or Nitinol hypo tube. The distal filter may need to be gently engaged to the vessel wall to allow the connection guidewire to be tensioned removing any slack or loop within the aortic arch. This may be possible with engagement barbs restricting proximal motion of the device in the vessel when deployed. Other means may be a stronger force in the memory metal loop to keep the device opposed to the wall. Now the circulation to the brain is protected and the aortic arch is clear from obstruction the normal procedure can occur. Examples of these procedures include but are not limited to: [0042] Coronary stenting [0043] Aortic valve replacement via catheterization [0044] Aortic or mitral valve replacement via transapical [0045] Aortic balloon valvuloplasty [0046] Mitral valvuloplasty [0047] Mitral valve replacement via catheterization [0048] Diagnostic catheterization [0049] Surgical valve replacement (aortic or mitral) [0050] Surgical valve repair (aortic or mitral) [0051] Annuloplasty ring placement [0052] Atrial fibrillation catheterization [0053] PFO closure (surgical or catheter based) [0054] Left atrial appendage closure (catheter or surgical)
Once the procedure has been completed the filters may be removed immediately or left in place if an antitrombotic coating is added or the patient remains on blood thinning agents to limit clot from forming on the filters. It may be advantageous to leave the filters in for a period of twenty four hours as the patient begins to recover. When removal is necessary the goal is to not dislodge any trapped emboli within the filter. Conventionally this is accomplished by pulling the filter into a larger recovery sheath to first close the open end of the filter and draw the remaining portion safely back into the recovery catheter. With the filters being opposed in direction it may be advantageous to move the distal filter into the proximal filter and recover them both together in a nested orientation.
This application is a continuation of U.S. application Ser. No. 16/934,962, filed Jul. 21, 2020, which is a continuation of U.S. Ser. No. 15/838,949, filed Dec. 12, 2017, which is a continuation of U.S. application Ser. No. 13/738,847, filed Jan. 10, 2013, which is a continuation of U.S. application Ser. No. 12/689,997, filed Jan. 19, 2010, now U.S. Pat. No. 8,372,108, which claims priority benefit under 35 U. S. C. .sctn. 119(e) to U.S. Provisional Application No. 61/145,149, filed Jan. 16, 2009, entitled “Intravascular Blood Filter,” all of which applications are hereby incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
3472230 | Fogarty | Oct 1969 | A |
4619246 | Molgaard-Nielsen et al. | Oct 1986 | A |
4630609 | Chin | Dec 1986 | A |
4650466 | Luther | Mar 1987 | A |
4706671 | Weinrib | Nov 1987 | A |
4723549 | Wholey et al. | Feb 1988 | A |
4873978 | Ginsburg | Oct 1989 | A |
5108419 | Reger | Apr 1992 | A |
5192286 | Phan et al. | Mar 1993 | A |
5200248 | Thompson et al. | Apr 1993 | A |
5329923 | Lundquist | Jul 1994 | A |
5348545 | Shani et al. | Sep 1994 | A |
5381782 | DeLaRama et al. | Jan 1995 | A |
5395327 | Lundquist et al. | Mar 1995 | A |
5613980 | Chauhan | Mar 1997 | A |
5624430 | Eton et al. | Apr 1997 | A |
5662671 | Barbut et al. | Sep 1997 | A |
5680873 | Berg et al. | Oct 1997 | A |
5707389 | Louw et al. | Jan 1998 | A |
5766151 | Valley et al. | Jun 1998 | A |
5779716 | Cano et al. | Jul 1998 | A |
5814064 | Daniel et al. | Sep 1998 | A |
5827324 | Cassell | Oct 1998 | A |
5833650 | Imran | Nov 1998 | A |
5848964 | Samuels | Dec 1998 | A |
5897529 | Ponzi | Apr 1999 | A |
5897819 | Miyata et al. | Apr 1999 | A |
5910154 | Tsugita et al. | Jun 1999 | A |
5910364 | Miyata et al. | Jun 1999 | A |
5911734 | Tsugita et al. | Jun 1999 | A |
5935139 | Bates | Aug 1999 | A |
5980555 | Barbut et al. | Nov 1999 | A |
5989281 | Barbut et al. | Nov 1999 | A |
5993469 | McKenzie et al. | Nov 1999 | A |
6001118 | Daniel et al. | Dec 1999 | A |
6010522 | Barbut et al. | Jan 2000 | A |
6027520 | Tsugita et al. | Feb 2000 | A |
6042598 | Tsugita et al. | Mar 2000 | A |
6045547 | Ren et al. | Apr 2000 | A |
6051014 | Jang | Apr 2000 | A |
6080140 | Swaminathan et al. | Jun 2000 | A |
6083239 | Addis | Jul 2000 | A |
6096053 | Bates | Aug 2000 | A |
6099534 | Bates et al. | Aug 2000 | A |
6120494 | Jonkman | Sep 2000 | A |
6126673 | Kim et al. | Oct 2000 | A |
6129739 | Khosravi | Oct 2000 | A |
6142987 | Tsugita | Nov 2000 | A |
6146396 | Konya | Nov 2000 | A |
6152946 | Broome et al. | Nov 2000 | A |
6171328 | Addis | Jan 2001 | B1 |
6179851 | Barbut et al. | Jan 2001 | B1 |
6179861 | Khosravi et al. | Jan 2001 | B1 |
6203561 | Ramee et al. | Mar 2001 | B1 |
6214026 | Lepak et al. | Apr 2001 | B1 |
6235045 | Barbut et al. | May 2001 | B1 |
6245087 | Addis | Jun 2001 | B1 |
6245088 | Lowery | Jun 2001 | B1 |
6245089 | Daniel et al. | Jun 2001 | B1 |
6264663 | Cano | Jul 2001 | B1 |
6270513 | Tsugita et al. | Aug 2001 | B1 |
6277138 | Levinson et al. | Aug 2001 | B1 |
6287321 | Jang | Sep 2001 | B1 |
6290710 | Cryer et al. | Sep 2001 | B1 |
6309399 | Barbut et al. | Oct 2001 | B1 |
6325815 | Kusleika et al. | Dec 2001 | B1 |
6336934 | Gilson et al. | Jan 2002 | B1 |
6336116 | Brooks et al. | Feb 2002 | B1 |
6361545 | Macoviak et al. | Mar 2002 | B1 |
6364900 | Heuser | Apr 2002 | B1 |
6371970 | Khosravi | Apr 2002 | B1 |
6371971 | Tsugita et al. | Apr 2002 | B1 |
6375628 | Zadno-Azizi et al. | Apr 2002 | B1 |
6383174 | Eder | May 2002 | B1 |
6383205 | Samson | May 2002 | B1 |
6440120 | Maahs | Aug 2002 | B1 |
6454799 | Schreck | Sep 2002 | B1 |
6485502 | Don Michael | Nov 2002 | B2 |
6499487 | McKenzie et al. | Dec 2002 | B1 |
6517559 | O'Connell | Feb 2003 | B1 |
6530939 | Hopkins et al. | Mar 2003 | B1 |
6537297 | Tsugita et al. | Mar 2003 | B2 |
6544279 | Hopkins et al. | Apr 2003 | B1 |
6558356 | Barbut | May 2003 | B2 |
6589263 | Hopkins et al. | Jul 2003 | B1 |
6595983 | Voda | Jul 2003 | B2 |
6605102 | Mazzocchi | Aug 2003 | B1 |
6616679 | Khosravi et al. | Sep 2003 | B1 |
6620148 | Tsugita | Sep 2003 | B1 |
6620182 | Khosravi et al. | Sep 2003 | B1 |
6648837 | Kato et al. | Nov 2003 | B2 |
6663652 | Daniel et al. | Dec 2003 | B2 |
6676682 | Tsugita et al. | Jan 2004 | B1 |
6712834 | Yassour et al. | Mar 2004 | B2 |
6712835 | Mazzocchi | Mar 2004 | B2 |
6719717 | Johnson et al. | Apr 2004 | B1 |
6726621 | Suon et al. | Apr 2004 | B2 |
6726651 | Robinson et al. | Apr 2004 | B1 |
6726701 | Gilson | Apr 2004 | B2 |
6740061 | Oslund | May 2004 | B1 |
6817999 | Berube et al. | Nov 2004 | B2 |
6830579 | Barbut | Dec 2004 | B2 |
6843798 | Kusleika et al. | Jan 2005 | B2 |
6872216 | Daniel | Mar 2005 | B2 |
6881194 | Miyata et al. | Apr 2005 | B2 |
6887258 | Denison et al. | May 2005 | B2 |
6905490 | Parodi | Jun 2005 | B2 |
6907298 | Smits et al. | Jun 2005 | B2 |
6958074 | Russell | Oct 2005 | B2 |
6969396 | Krolik et al. | Nov 2005 | B2 |
7011094 | Rapacki et al. | Mar 2006 | B2 |
7048752 | Mazzocchi | May 2006 | B2 |
7094249 | Broome | Aug 2006 | B1 |
7115134 | Chambers | Oct 2006 | B2 |
7160255 | Saadat | Jan 2007 | B2 |
7169161 | Bonnette et al. | Jan 2007 | B2 |
7169165 | Belef et al. | Jan 2007 | B2 |
7182757 | Miyata et al. | Feb 2007 | B2 |
7214237 | Don Michael | May 2007 | B2 |
7278974 | Kato et al. | Oct 2007 | B2 |
7303575 | Ogle | Dec 2007 | B2 |
7306618 | Demond et al. | Dec 2007 | B2 |
7313445 | McVenes et al. | Dec 2007 | B2 |
7323001 | Clubb et al. | Jan 2008 | B2 |
7329278 | Seguin et al. | Feb 2008 | B2 |
7399308 | Borillo et al. | Jul 2008 | B2 |
7410491 | Hopkins | Aug 2008 | B2 |
7493154 | Bonner et al. | Feb 2009 | B2 |
7559925 | Goldfarb et al. | Jul 2009 | B2 |
7572272 | Denison et al. | Aug 2009 | B2 |
7621904 | McFerran et al. | Nov 2009 | B2 |
7722634 | Panetta et al. | May 2010 | B2 |
7766961 | Patel et al. | Aug 2010 | B2 |
7918859 | Katoh et al. | Apr 2011 | B2 |
7922732 | Mazzocchi et al. | Apr 2011 | B2 |
7976562 | Bressler et al. | Jul 2011 | B2 |
7998104 | Chang | Aug 2011 | B2 |
8002790 | Brady et al. | Aug 2011 | B2 |
8021351 | Boldenow et al. | Sep 2011 | B2 |
8052713 | Khosravi et al. | Nov 2011 | B2 |
8092483 | Galdonik et al. | Jan 2012 | B2 |
8372108 | Lashinski | Feb 2013 | B2 |
8382788 | Galdonik | Feb 2013 | B2 |
8460335 | Carpenter | Jun 2013 | B2 |
8518073 | Lashinski | Aug 2013 | B2 |
8753370 | Lashinski | Jun 2014 | B2 |
8876796 | Fifer et al. | Nov 2014 | B2 |
8974489 | Lashinski | Mar 2015 | B2 |
9017364 | Fifer et al. | Apr 2015 | B2 |
9055997 | Fifer et al. | Jun 2015 | B2 |
9259306 | Fifer et al. | Feb 2016 | B2 |
9326843 | Lee et al. | May 2016 | B2 |
9345565 | Fifer et al. | May 2016 | B2 |
9480548 | Carpenter | Nov 2016 | B2 |
9492264 | Fifer et al. | Nov 2016 | B2 |
9566144 | Purcell et al. | Feb 2017 | B2 |
9636205 | Lee et al. | May 2017 | B2 |
9943395 | Fifer et al. | Apr 2018 | B2 |
20010041858 | Ray et al. | Nov 2001 | A1 |
20020022858 | Demond et al. | Feb 2002 | A1 |
20020026145 | Bagaoisan et al. | Feb 2002 | A1 |
20020055767 | Forde et al. | May 2002 | A1 |
20020068015 | Polaschegg et al. | Jun 2002 | A1 |
20020077596 | McKenzie et al. | Jun 2002 | A1 |
20020095170 | Krolik et al. | Jul 2002 | A1 |
20020095172 | Mazzocchi et al. | Jul 2002 | A1 |
20020123761 | Barbut et al. | Sep 2002 | A1 |
20020161394 | Macoviak et al. | Oct 2002 | A1 |
20020165571 | Herbert et al. | Nov 2002 | A1 |
20020165573 | Barbut | Nov 2002 | A1 |
20030100919 | Hopkins et al. | May 2003 | A1 |
20030130684 | Brady et al. | Jul 2003 | A1 |
20030144686 | Martinez et al. | Jul 2003 | A1 |
20030171770 | Kusleika et al. | Sep 2003 | A1 |
20030199960 | Paskar | Oct 2003 | A1 |
20040002730 | Denison et al. | Jan 2004 | A1 |
20040006370 | Tsugita | Jan 2004 | A1 |
20040044350 | Martin et al. | Mar 2004 | A1 |
20040044360 | Lowe | Mar 2004 | A1 |
20040064092 | Tsugita et al. | Apr 2004 | A1 |
20040093015 | Ogle | May 2004 | A1 |
20040138529 | Wiltshire | Jul 2004 | A1 |
20040167565 | Beulke et al. | Aug 2004 | A1 |
20040193206 | Gerberding | Sep 2004 | A1 |
20040215167 | Belson | Oct 2004 | A1 |
20040215230 | Frazier | Oct 2004 | A1 |
20040220611 | Ogle | Nov 2004 | A1 |
20040225321 | Krolik et al. | Nov 2004 | A1 |
20040230220 | Osborne | Nov 2004 | A1 |
20040243175 | Don Michael | Dec 2004 | A1 |
20040254601 | Eskuri | Dec 2004 | A1 |
20040254602 | Lehe et al. | Dec 2004 | A1 |
20050010285 | Lambrecht et al. | Jan 2005 | A1 |
20050065397 | Saadat et al. | Mar 2005 | A1 |
20050080356 | Dapolito et al. | Apr 2005 | A1 |
20050085847 | Galdonik et al. | Apr 2005 | A1 |
20050101987 | Salahieh | May 2005 | A1 |
20050131449 | Salahieh et al. | Jun 2005 | A1 |
20050137696 | Salahieh | Jun 2005 | A1 |
20050177132 | Lentz et al. | Aug 2005 | A1 |
20050209631 | Galdonik et al. | Sep 2005 | A1 |
20050277976 | Galdonik et al. | Dec 2005 | A1 |
20060015136 | Besselink | Jan 2006 | A1 |
20060015138 | Gertner | Jan 2006 | A1 |
20060030877 | Martinez et al. | Feb 2006 | A1 |
20060041188 | Dirusso et al. | Feb 2006 | A1 |
20060047301 | Ogle | Mar 2006 | A1 |
20060089618 | McFerran et al. | Apr 2006 | A1 |
20060089666 | Linder et al. | Apr 2006 | A1 |
20060100658 | Obana et al. | May 2006 | A1 |
20060100662 | Daniel et al. | May 2006 | A1 |
20060129180 | Tsugita et al. | Jun 2006 | A1 |
20060135961 | Rosenman et al. | Jun 2006 | A1 |
20060136043 | Cully et al. | Jun 2006 | A1 |
20060149350 | Patel et al. | Jul 2006 | A1 |
20060161241 | Barbut et al. | Jul 2006 | A1 |
20060200047 | Galdonik et al. | Sep 2006 | A1 |
20060200191 | Zadno-Azizi | Sep 2006 | A1 |
20060259066 | Euteneuer | Nov 2006 | A1 |
20070005131 | Taylor | Jan 2007 | A1 |
20070043259 | Jaffe et al. | Feb 2007 | A1 |
20070060944 | Boldenow et al. | Mar 2007 | A1 |
20070088244 | Miller et al. | Apr 2007 | A1 |
20070088383 | Pal et al. | Apr 2007 | A1 |
20070173878 | Heuser | Jul 2007 | A1 |
20070191880 | Cartier et al. | Aug 2007 | A1 |
20070208302 | Webster et al. | Sep 2007 | A1 |
20070244504 | Keegan et al. | Oct 2007 | A1 |
20080004687 | Barbut | Jan 2008 | A1 |
20080033467 | Miyamoto et al. | Feb 2008 | A1 |
20080058860 | Demond et al. | Mar 2008 | A1 |
20080065145 | Carpenter | Mar 2008 | A1 |
20080065147 | Mazzocchi et al. | Mar 2008 | A1 |
20080086110 | Galdonik et al. | Apr 2008 | A1 |
20080109088 | Galdonik et al. | May 2008 | A1 |
20080125848 | Kusleika et al. | May 2008 | A1 |
20080147013 | Breton | Jun 2008 | A1 |
20080154153 | Heuser | Jun 2008 | A1 |
20080172066 | Galdonik et al. | Jun 2008 | A9 |
20080188884 | Gilson et al. | Aug 2008 | A1 |
20080234722 | Bonnette et al. | Sep 2008 | A1 |
20080262442 | Carlin et al. | Oct 2008 | A1 |
20080300462 | Intoccia et al. | Dec 2008 | A1 |
20090024072 | Criado et al. | Jan 2009 | A1 |
20090024153 | Don Michael | Jan 2009 | A1 |
20090069840 | Hallisey | Mar 2009 | A1 |
20090198269 | Hannes et al. | Aug 2009 | A1 |
20090203962 | Miller et al. | Aug 2009 | A1 |
20090254172 | Grewe et al. | Oct 2009 | A1 |
20090281619 | Le | Nov 2009 | A1 |
20090287187 | Legaspi et al. | Nov 2009 | A1 |
20090326575 | Galdonik | Dec 2009 | A1 |
20100004633 | Rothe et al. | Jan 2010 | A1 |
20100010476 | Galdonik et al. | Jan 2010 | A1 |
20100063537 | Ren et al. | Mar 2010 | A1 |
20100106182 | Patel et al. | Apr 2010 | A1 |
20100191276 | Lashinski | Jun 2010 | A1 |
20100179583 | Carpenter et al. | Jul 2010 | A1 |
20100179584 | Carpenter et al. | Jul 2010 | A1 |
20100179585 | Carpenter et al. | Jul 2010 | A1 |
20100179647 | Carpenter et al. | Jul 2010 | A1 |
20100185216 | Garrison et al. | Jul 2010 | A1 |
20100185231 | Lashinski | Jul 2010 | A1 |
20100211095 | Carpenter | Aug 2010 | A1 |
20100228280 | Groothius et al. | Sep 2010 | A1 |
20100312268 | Belson | Dec 2010 | A1 |
20100324589 | Carpenter et al. | Dec 2010 | A1 |
20110066221 | White et al. | Mar 2011 | A1 |
20110144572 | Kassab | Jun 2011 | A1 |
20120046739 | Von Oepen et al. | Feb 2012 | A1 |
20120095500 | Heuser | Apr 2012 | A1 |
20120172916 | Fifer et al. | Jul 2012 | A1 |
20120203265 | Heuser | Aug 2012 | A1 |
20130123835 | Anderson et al. | May 2013 | A1 |
20130131714 | Wang et al. | May 2013 | A1 |
20130231694 | Lashinski | Sep 2013 | A1 |
20140052170 | Heuser et al. | Feb 2014 | A1 |
20140094843 | Heuser | Apr 2014 | A1 |
20140100597 | Wang et al. | Apr 2014 | A1 |
20140243877 | Lee et al. | Aug 2014 | A9 |
20140282379 | Lee et al. | Sep 2014 | A1 |
20150039016 | Naor et al. | Feb 2015 | A1 |
20150209131 | Fifer et al. | Jul 2015 | A1 |
20150230910 | Lashinski et al. | Aug 2015 | A1 |
20150335416 | Fifer et al. | Nov 2015 | A1 |
20160058541 | Schotzko et al. | Mar 2016 | A1 |
20160262864 | Von Mangoldt et al. | Sep 2016 | A1 |
20160310255 | Purcell et al. | Oct 2016 | A1 |
20170042658 | Lee et al. | Feb 2017 | A1 |
20170112609 | Purcell et al. | Apr 2017 | A1 |
20170181834 | Fifer et al. | Jun 2017 | A1 |
20170202657 | Lee et al. | Jul 2017 | A1 |
Number | Date | Country |
---|---|---|
10049812 | Apr 2002 | DE |
1400257 | Mar 2004 | EP |
1253871 | Feb 2007 | EP |
2303384 | Apr 2011 | EP |
2391303 | Dec 2011 | EP |
2480165 | Aug 2012 | EP |
2658476 | Nov 2013 | EP |
2387427 | Aug 2014 | EP |
2003505216 | Feb 2003 | JP |
2003526451 | Sep 2003 | JP |
2003290231 | Oct 2003 | JP |
3535098 | Jun 2004 | JP |
2006500187 | Jan 2006 | JP |
2008511401 | Apr 2008 | JP |
2008515463 | May 2008 | JP |
2011525405 | Sep 2011 | JP |
9923976 | May 1999 | WO |
0167989 | Sep 2001 | WO |
2004026175 | Apr 2004 | WO |
2005118050 | Dec 2005 | WO |
2006026371 | Mar 2006 | WO |
2008033845 | Mar 2008 | WO |
2008100790 | Aug 2008 | WO |
2008113857 | Sep 2008 | WO |
2009032834 | Mar 2009 | WO |
2010008451 | Jan 2010 | WO |
2010081025 | Jul 2010 | WO |
2010083527 | Jul 2010 | WO |
2010088520 | Aug 2010 | WO |
2011034718 | Mar 2011 | WO |
2011017103 | Oct 2011 | WO |
2012092377 | Jul 2012 | WO |
Entry |
---|
Internet Archive Wayback Machine; Fiber Innovative Technology: FIT Capabilities; downloaded from http://web.archive.org/web/20010217040848/http://www.fitfibers.com/capabilities.htm (Archived Feb. 17, 2001; printed on Dec. 12, 2016). |
Internet Archive Wayback Machine; Fiber Innovative Technology: 4DG Fibers; downloaded from http://web.archive.org/web/20011030070010/http://fitfibers.com/4DG_Fibers.htm (Archived Oct. 30, 2001; printed on Dec. 12, 2016). |
Internet Archive Wayback Machine; Fiber Innovative Technology: FIT Products; downloaded from http://web.archive.org/web/20010408003529/http://www.fitfibers.com/product.htm (Archived Apr. 8, 2001; printed on Dec. 12, 2016). |
Office Action for U.S. Appl. No. 15/080,345 dated Jan. 12, 2018, in 13 pages. |
Final Office Action for U.S. Appl. No. 12/689,997 dated Nov. 5, 2012, in 11 pages. |
Final Office Action for U.S. Appl. No. 12/871,708 dated May 28, 2014, in 31 pages. |
Final Office Action for U.S. Appl. No. 13/497,235 dated Oct. 22, 2015, in 34 pages. |
International Search Report in Application No. PCT/US2010/021417 dated Aug. 23, 2010, in 4 pages. |
International Search Report in Application No. PCT/US2010/047166 dated Apr. 27, 2011, in 7 pages. |
Notice of Allowance for U.S. Appl. No. 12/689,997 dated Jan. 9, 2013, in 9 pages. |
Notice of Allowance for U.S. Appl. No. 12/871,708 dated Dec. 23, 2015, in 16 pages. |
Notice of Allowance for U.S. Appl. No. 13/497,235 dated Jan. 6, 2017, in 16 pages. |
Office Action for U.S. Appl. No. 12/689,997 dated Apr. 4, 2012 in 13 pages. |
Office Action for U.S. Appl. No. 12/871,708 dated Oct. 11, 2013 in 34 pages. |
Office Action for U.S. Appl. No. 12/871,708 dated Mar. 12, 2015, in 36 pages. |
Office Action for U.S. Appl. No. 13/497,235 dated Jun. 15, 2016, in 25 pages. |
Supplementary European Search Report in Application No. PCT/US2010/021417 dated Nov. 28, 2012, in 5 pages. |
Final Office Action for U.S. Appl. No. 13/738,847 dated Sep. 11, 2015 in 12 pages. |
Final Office Action for U.S. Appl. No. 13/738,847 dated Sep. 13, 2017 in 10 pages. |
Office Action for U.S. Appl. No. 13/738,847 dated Apr. 29, 2015 in 16 pages. |
Office Action for U.S. Appl. No. 13/738,847 dated May 20, 2016, in 9 pages. |
Office Action for U.S. Appl. No. 13/738,847 dated Jan. 23. 2017, in 6 pages. |
Office Action for U.S. Appl. No. 13/738,847 dated May 10, 2017 in 11 pages. |
Office Action for U.S. Appl. No. 13,497,235 dated Apr. 2, 2015, in 21 pages. |
International Search Report in Application No. PCT/US2010/043390 dated Apr. 8, 2011, in 11 pages. |
International Search Report in Application No. PCT/US2011/067598 dated May 10, 2012, in 7 pages. |
International Search Report in Application No. PCT/US2010/022590 dated Jan. 29, 2010, in 4 pages. |
Search Opinion in European Application No. 09798236 dated Jul. 20, 2012, in 6 pages. |
U.S. Appl. No. 16/934,962, filed Jul. 21, 2020, now U.S. Pat. No. 11,364,106. |
U.S. Appl. No. 15/838,949, filed Dec. 12, 2017, now U.S. Pat. No. 10,743,977. |
U.S. Appl. No. 13/738,847, filed Jan. 10, 2013. |
Number | Date | Country | |
---|---|---|---|
20220280274 A1 | Sep 2022 | US |
Number | Date | Country | |
---|---|---|---|
61145149 | Jan 2009 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16934962 | Jul 2020 | US |
Child | 17752209 | US | |
Parent | 15838949 | Dec 2017 | US |
Child | 16934962 | US | |
Parent | 13738847 | Jan 2013 | US |
Child | 15838949 | US | |
Parent | 12689997 | Jan 2010 | US |
Child | 13738847 | US |